In other tumor types, the upregulation of the SDHA gene was driven by different mechanisms, including SDHA promoter hypomethylation in breast cancer [46] or increased histone acetylation within the SDHA promoter in multiple myeloma [68]. The gene discussed is SDHA; the disease is plasma cell myeloma.